Tumor heterogeneity refers to the existence of diverse subpopulations of cancer cells within a single tumor, contributing to variations in genetic, phenotypic, and behavioral characteristics. This complexity poses significant challenges in diagnosis, treatment, and understanding of cancer progression, as different subclones may respond differently to therapies and evolve over time.